Literature DB >> 24055327

Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial.

Thomas J Povsic1, Richard Sloane, Jennifer B Green, Jiying Zhou, Carl F Pieper, Megan P Pearson, Eric D Peterson, Harvey J Cohen, Miriam C Morey.   

Abstract

BACKGROUND: One theory of aging and disease development is that chronic injury (pathology) results in activation of regenerative processes and initial repair, with overt disease arising only after exhaustion of reparative capability leads to inadequate repair. While depletion of circulating progenitor cells (CPCs) has been noted in diabetes, the degree to which CPC depletion predates and is associated with propensity to develop overt disease is unclear.
METHODS: The Enhanced Fitness trial enrolled overweight/obese (body mass index >25) sedentary patients with glucose intolerance but without overt diabetes. Baseline CPCs were measured in 129 patients based on the cell surface markers CD34, CD133, and aldehyde dehydrogenase (ALDH) activity. HgbA1C, fasting insulin and glucose levels, and HOMA calculations were ascertained.
RESULTS: Lower counts of early angiogenic CPCs identified as CD34(+), CD34(+)CD133(+), and ALDH-bright (ALDH(br)) cells were associated with impairments in glucose homeostasis as reflected by HgbA1C, but not fasting insulin, glucose, or HOMA-IR. These associations remained when corrected for age and cardiovascular risk factors. CONCLUSIONS/
INTERPRETATION: The numbers of CD34(+) and ALDH(br) CPCs were significantly lower in patients with impaired glucose tolerance. Depletion of reparative capacity as reflected by loss of CPCs may presage overt disease as exemplified in this pre-diabetes model.
© 2013.

Entities:  

Keywords:  Disease progression; Etiology; Pathophysiology; Prediabetes; Progenitor cells; Stem cells

Mesh:

Substances:

Year:  2013        PMID: 24055327      PMCID: PMC3874717          DOI: 10.1016/j.jdiacomp.2013.08.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  15 in total

Review 1.  On the memory of a chronic illness.

Authors:  Pascal J Goldschmidt-Clermont; Eric D Peterson
Journal:  Sci Aging Knowledge Environ       Date:  2003-11-12

Review 2.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

Authors:  Susumu Seino; Tadao Shibasaki; Kohtaro Minami
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

3.  High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.

Authors:  Yung-Hsiang Chen; Shing-Jong Lin; Feng-Yen Lin; Tao-Cheng Wu; Chen-Rong Tsao; Po-Hsun Huang; Po-Len Liu; Yuh-Lien Chen; Jaw-Wen Chen
Journal:  Diabetes       Date:  2007-03-26       Impact factor: 9.461

4.  Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase.

Authors:  Shintaro Kuki; Toshio Imanishi; Katsunobu Kobayashi; Yoshiki Matsuo; Masahiro Obana; Takashi Akasaka
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

5.  Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors:  G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

6.  Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Saula de Kreutzenberg; Carlo Agostini; Florian Seeger; Stefanie Dimmeler; Andreas Zeiher; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

7.  Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity.

Authors:  Thomas J Povsic; Katherine L Zavodni; Francine L Kelly; Shoukang Zhu; Pascal J Goldschmidt-Clermont; Chunming Dong; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2007-11-19       Impact factor: 24.094

8.  Enhanced fitness: a randomized controlled trial of the effects of home-based physical activity counseling on glycemic control in older adults with prediabetes mellitus.

Authors:  Miriam C Morey; Carl F Pieper; David E Edelman; William S Yancy; Jennifer B Green; Helen Lum; Matthew J Peterson; Richard Sloane; Patricia A Cowper; Hayden B Bosworth; Kim M Huffman; James T Cavanaugh; Katherine S Hall; Megan P Pearson; Gregory A Taylor
Journal:  J Am Geriatr Soc       Date:  2012-09       Impact factor: 5.562

9.  Lessons learned when innovations go awry: a baseline description of a behavioral trial-the Enhancing Fitness in Older Overweight Veterans with Impaired Fasting Glucose study.

Authors:  Katherine S Hall; Carl F Pieper; David E Edelman; William S Yancy; Jennifer B Green; Helen Lum; Matthew J Peterson; Richard Sloane; Patricia A Cowper; Hayden B Bosworth; Kim M Huffman; James T Cavanaugh; Jennifer G Chapman; Megan P Pearson; Teresa A Howard; Carola C Ekelund; Beverly L McCraw; Joi B Burrell; Gregory A Taylor; Miriam C Morey
Journal:  Transl Behav Med       Date:  2011-11       Impact factor: 3.046

10.  Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data.

Authors:  Simon Brunner; Gerit-Holger Schernthaner; Miriam Satler; Marie Elhenicky; Florian Hoellerl; Katharina E Schmid-Kubista; Florian Zeiler; Susanne Binder; Guntram Schernthaner
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-21       Impact factor: 4.799

View more
  5 in total

1.  Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase/JNK signaling axis.

Authors:  Jianfei Chen; Jun Jing; Shiyong Yu; Minbao Song; Hu Tan; Bin Cui; Lan Huang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 2.  Current State of Stem Cell Therapy for Ischemic Heart Disease.

Authors:  Thomas J Povsic
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

3.  CD133 expression in circulating hematopoietic progenitor cells.

Authors:  Thomas R Cimato; Alexis Conway; Julianne Nichols; Paul K Wallace
Journal:  Cytometry B Clin Cytom       Date:  2018-10-16       Impact factor: 3.248

4.  Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.

Authors:  Nabanita Kundu; Cleyton C Domingues; Cyril Chou; Neeki Ahmadi; Sara Houston; D Joseph Jerry; Sabyasachi Sen
Journal:  J Am Heart Assoc       Date:  2017-04-01       Impact factor: 5.501

5.  Reduced Circulating Endothelial Progenitor Cells and Downregulated GTCPH I Pathway Related to Endothelial Dysfunction in Premenopausal Women with Isolated Impaired Glucose Tolerance.

Authors:  Juan Liu; Xiangbin Xing; Xinlin Wu; Xiang Li; Shun Yao; Zi Ren; Haitao Zeng; Shaohong Wu
Journal:  Cardiol Res Pract       Date:  2020-01-25       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.